Hormone replacement therapy (HRT) replaces the estrogen and progesterone your body stops producing during menopause. At standard doses, it reduces hot flashes and night sweats by 75% to 80%, making it the most effective treatment available for menopause symptoms. But its effects extend well beyond temperature regulation, influencing bone density, heart health, urogenital tissue, sleep, and mood.
How HRT Works in Your Body
During menopause, your ovaries dramatically slow their production of estrogen and progesterone. These hormones don’t just regulate your menstrual cycle. They interact with receptors throughout your body, in your bones, brain, blood vessels, skin, and urinary tract, switching genes on and off that control everything from bone rebuilding to temperature regulation. When hormone levels drop, all of those systems feel the change.
HRT supplies your body with hormones that bind to those same receptors and restore the signaling that menopause disrupted. Women who still have a uterus typically take both estrogen and a form of progesterone (to protect the uterine lining from overgrowth). Women who’ve had a hysterectomy usually take estrogen alone. The hormones come from several sources: some are synthesized to be chemically identical to what your body produces (often called “bioidentical”), while others are derived from plant or animal sources with slightly different molecular structures.
Relief From Hot Flashes and Night Sweats
Vasomotor symptoms, the hot flashes and night sweats that are the hallmark of menopause, are the most common reason women seek HRT. Standard-dose estrogen reduces moderate to severe episodes by 75% to 80% compared to no treatment. Even low-dose formulations cut episodes by about 65%, which is still substantially better than the 35% to 40% improvement seen with placebo.
The timeline varies. Some women notice subtle shifts in the first one to two weeks, particularly fewer night sweats and slightly better sleep. By months two to three, the improvement is usually more dramatic and consistent. If hot flashes are your primary concern, you can generally expect meaningful relief within the first month or two of consistent use.
Effects on Sleep, Mood, and Thinking
Sleep disruption during menopause isn’t just caused by night sweats. Estrogen and progesterone both influence sleep architecture directly. Many women notice improved sleep within the first few weeks of starting HRT, especially when insomnia has been tied to nighttime temperature spikes.
Mood changes tend to follow a slightly slower timeline. Increased emotional stability typically emerges between weeks four and eight. By months two to three, women often report clearer thinking, better concentration, and reduced irritability. These cognitive and emotional effects reflect estrogen’s widespread role in brain signaling, not just its influence on body temperature.
Vaginal and Urinary Health
One of estrogen’s less discussed roles is maintaining the health of vaginal and urinary tract tissues. After menopause, these tissues thin, lose elasticity, and produce less natural lubrication. The result, called genitourinary syndrome of menopause, can cause vaginal dryness, pain during sex, irritation from everyday activities like wiping after urination or wearing certain clothing, and increased urinary tract infections.
Low-dose estrogen applied directly to the vulva and vagina effectively relieves these symptoms. Improvements usually appear within a few weeks to months of consistent use. This local approach delivers estrogen right where it’s needed with minimal absorption into the rest of the body, making it an option even for some women who can’t use systemic HRT. Systemic HRT (pills or patches) also helps, though local treatment is often more targeted for urogenital symptoms specifically.
Bone Protection
Estrogen plays a central role in bone maintenance. It slows the activity of cells that break down old bone, keeping the balance between bone loss and bone rebuilding in check. When estrogen drops at menopause, bone breakdown accelerates, and women can lose significant bone density in the first several years. This is why osteoporosis and fracture risk climb sharply after menopause.
HRT counteracts this process. It slows bone loss and maintains density for as long as you take it. This translates to meaningful reductions in fractures of the hip, spine, and other sites. However, the bone-protective effect fades after you stop treatment, so HRT alone isn’t considered a permanent solution for osteoporosis prevention. It’s most useful for women who are already taking HRT for symptom relief and getting the bone benefit as an added advantage.
Heart Health and the Timing Window
The relationship between HRT and cardiovascular health depends heavily on when you start. The “timing hypothesis,” now supported by substantial evidence, proposes that HRT initiated within 10 years of menopause onset or before age 60 may protect the heart, while starting later may increase cardiovascular risk.
The numbers illustrate this clearly. Women who began estrogen-only therapy within 10 years of menopause showed a 41% reduction in coronary heart disease risk. Combined estrogen-plus-progesterone therapy in the same window showed a trend toward 24% reduction. In stark contrast, women who started HRT more than 20 years after menopause or at age 70 and older experienced increased coronary risk. The likely explanation is that estrogen helps maintain healthy, flexible blood vessels but can destabilize vessels that have already developed significant plaque buildup.
Current guidelines from the North American Menopause Society reflect this: for women younger than 60 or within 10 years of menopause who have bothersome symptoms and no contraindications, the benefits of HRT generally outweigh the risks. Starting HRT purely for disease prevention in women past that window is not recommended.
How You Take It Matters
HRT comes in several forms: oral tablets, skin patches, gels, sprays, vaginal rings, and creams. The choice isn’t just about convenience. The delivery method affects your risk profile, particularly for blood clots.
Oral estrogen passes through the liver before reaching the rest of your body, which triggers increased production of clotting factors. A large study using UK primary care data found that oral HRT was associated with a 58% increased risk of venous blood clots compared to non-use. Transdermal HRT (patches and gels), which absorbs through the skin and bypasses the liver, showed no increased clot risk at all. Compared head to head, oral HRT carried 70% higher clot risk than transdermal. None of the transdermal preparations, whether estrogen-only or combined, low-dose or high-dose, were linked to increased clot risk.
For women concerned about blood clots, or those with risk factors like obesity or a family history of clotting disorders, transdermal delivery offers a meaningful safety advantage.
Known Risks
The risk that gets the most attention is breast cancer. Combined HRT (estrogen plus progesterone) is associated with a small increase in breast cancer risk that grows with longer duration of use. Estrogen-only therapy carries a lower risk and, in some studies, has shown no increased risk or even a slight decrease. The absolute numbers are small: for most women using HRT for five years around the time of menopause, the additional risk translates to a few extra cases per 1,000 women.
Beyond breast cancer, oral HRT modestly raises the risk of stroke and blood clots, though as noted above, transdermal delivery largely eliminates the clotting concern. The overall risk picture depends on your age, how long ago menopause started, your personal and family medical history, and which formulation you use.
Who Should Not Use HRT
Systemic HRT is generally not recommended for women who have had breast or endometrial cancer, a stroke, a heart attack, blood clots, or liver disease. Women who are pregnant or may be pregnant should also avoid it. These aren’t absolute rules in every case, but they represent the standard contraindications that most clinicians follow. For women with these conditions, non-hormonal treatments for menopause symptoms are available.
What to Expect in the First Few Months
Starting HRT isn’t like flipping a switch. The first two weeks may bring subtle improvements in sleep, mood, or vaginal moisture. Some women also experience temporary side effects like breast tenderness, bloating, or spotting as their body adjusts. These typically settle within the first one to three months.
By months two to three, the broader effects become more apparent: more stable mood, better sleep quality, improved mental clarity, greater comfort during sex, and substantially fewer hot flashes. Most women reach a stable baseline by about three months, though fine-tuning the dose or delivery method can take longer. If you’re not seeing improvement after that window, adjusting the formulation or dosage is a reasonable next step.